US 10905770
Topical delivery of therapeutic agents using cell-penetrating peptides for the treatment of age-related macular degeneration and other eye diseases
granted A61KA61K2039/505A61K31/047
Quick answer
US patent 10905770 (Topical delivery of therapeutic agents using cell-penetrating peptides for the treatment of age-related macular degeneration and other eye diseases) held by MacRegen, Inc. expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MacRegen, Inc.
- Grant date
- Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K31/047, A61K31/065, A61K31/366